Repare Therapeutics News

Repare Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 27 12:39 ET

Repare Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 26 14:54 ET

Repare Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 25 19:30 ET

Repare Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 25 16:25 ET

Repare Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 25 16:25 ET

Repare Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jun 6, 2023 16:25 ET

Repare Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

May 10, 2023 13:17 ET

Repare Therapeutics | 424B5: Prospectus

Aug 4, 2022 17:00 ET

Repare Therapeutics | EFFECT: Others

Apr 26, 2022 00:15 ET

Repare Therapeutics | 424B5: Prospectus

Oct 28, 2021 17:27 ET

Repare Therapeutics | 424B5: Prospectus

Oct 27, 2021 16:54 ET

Repare Therapeutics | 424B4: Prospectus

Jun 19, 2020 16:38 ET

Repare Therapeutics | EFFECT: Others

Jun 19, 2020 00:15 ET

Repare Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Jun 18, 2020 21:44 ET

Repare Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Jun 17, 2020 16:27 ET

Repare Therapeutics | 8-A12B: Registration of a class of securities on a national securities exchange

Jun 16, 2020 16:47 ET